Search Results

Sachdev is an early career researcher in the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. She received her undergraduate degree in Biotechnology from KIIT University in India.

Arun Shukla from the Indian Institute of Technology in Kanpur, India. He earned his master's degree in biotechnology from Jawaharlal Nehru University in India and it was during Arun first started working on GPCRs and their structural characterization at the Max Planck Institute Arun Shukla on the web Indian Institute of Technology Dr.

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Oliver Hartley on the web LinkedIn Orion Biotechnology Dr. GPCR Ecosystem Enjoying the Dr.

Ralf Jockers Ralf Jockers studied in Cologne and received a Ph.D. in biotechnology and biochemistry from His laboratory is currently located at the Institute Cochin – Inserm (Paris, France).

Deputy Director, and Better Medicines Theme Leader of the Neuromedicines Discovery Centre at the Monash Institute Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology

oncology research led me to pursue a BSc in Biology & Economics from Carleton University, and an MSc in Biotechnology In my role at Orion Biotechnology, I work at the intersection of science and business, which includes Caron currently holds multiple scientific advisory roles in academia, industry and the National Institutes Undergraduate Research Program and is working to build relationships with key stakeholders through institutional

University of Montreal in Canada before training at Rockefeller University in New York and the National Institutes Sachdev is an early career researcher in the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. She received her undergraduate degree in Biotechnology from KIIT University in India. GPCR About Cam Sinh Lu Cam Sinh Lu is a PhD student at Monash Institute of Pharmaceutical Sciences, Monash

Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in During his master's studies, he specialized in Biomedical Biotechnology and Structural Biology/Biochemistry

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes Caroline Gorvin is a Wellcome Trust & Royal Society Sir Henry Dale Fellow at the Institute of Metabolism

following three years on the editorial teams of Nature Structural and Molecular Biology and Nature Biotechnology

in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology group of Martin Lohse at the Institute order to focus my research on class Frizzled GPCR s in the lab of Gunnar Schulte at the Karolinska Institute Hannes Schihada on the web Karolinska Institutet Twitter Adher´n Rise LinkedIn Dr.

Last summer, Julia worked at as the first-ever summer intern at Septerna, the GPCR-based biotechnology

Kathryn E Livingston is currently a Product Manager at Gator Bio , a biotechnology company providing

of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery and development biotechnology

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes

Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics Ltd , a biotechnology

Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr.

Elodie Dupuis earned her Master’s degree in biology and biotechnology engineering from the University She has been leading collaborative projects with public research institutes and pharmaceutical companies , most notably the joint Revvity/Institute of Functional Genomics team, EIDOS. Mathis holds a biotechnology engineering degree from the National School of Biomolecule Technology of

competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology Additionally, they explored the unique culture and structure of their Institute, highlighting its translational Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, research, highlighting the unique opportunities presented by their location and partnerships with other institutions

competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology Additionally, they explored the unique culture and structure of their Institute, highlighting its translational Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, research, highlighting the unique opportunities presented by their location and partnerships with other institutions

In this institution dear to the heart of GPCR enthusiasts given that its faculty personnel included Dr integrating the department of Cell Biology at the Centro de Investigación y de Estudios Avanzados del Instituto He also actively volunteers as an Associate Professor of the non-governmental organization Institut des

based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology

Engelenburg1, Joost Smolders1,3, and Jörg Hamann1,2 1Department of Neuroimmunology, Netherlands Institute Institute for Diabetes and Cancer, Helmholtz Centre Munich, Germany, 2. Institute of Innate Immunity, University Hospital Bonn, University of Bonn, 3. Professional Background Since 2021 Group Leader, Institute for Diabetes and Cancer, Helmholtz Diabetes Centre, Munich 2015 - 2018 Postdoctoral fellow, Department of Adipose Tissue Biology, Institute for

Gainetdinov is the Institute of Translational Biomedicine Director at Saint Petersburg State University Gainetdinov was a Senior Researcher in the Department of Neuroscience and Brain Technologies at the Italian Institute From 2013-2018, he was also a Professor at the Skolkovo Institute of Science and Technology (Skoltech Department of Cell Biology in 1996 as a postdoc and becoming faculty at Duke in 2000, he researched at the Institute 1992 from the Russian Academy of Medical Sciences and an M.D. in 1988 from the Second Moscow Medical Institute

, UK 2Proteomics Science Technology Platform, The Francis Crick Institute, UK" About Simeon R. the University of Sheffield followed up by obtaining a PhD in molecular neuroscience at the Sheffield Institute worked on mTOR in the pathogenesis of Tuberous Sclerosis Complex and then moved to the Francis Crick Institute Körner, Marek Benjamin; Dahse, Anne-Kristin; Ljaschenko, Dmitrij; Scholz, Nicole (Rudolf Schönheimer Institute Anne Bormann on the web Rudolf-Schönheimer-Institut für Biochemie Scholz Lab < Previous Session Next

and chair of the Department of Computational and Quantitative Medicine (DCQM) at the Beckman Research Institute Vaidehi received her Ph.D. in quantum chemistry from the Indian Institute of Technology in India, where became the director of biomolecular simulations at the Materials and Process Simulation Center, Beckman Institute Vaidehi joined the Beckman Research Institute of the City of Hope in 2006 as a Professor and became chair

Neuroscience Institute, Institute for Biophysical Dynamics, and Center for Mechanical Excitability, The Workshop Attendees Authors & Affiliations "Hee-Yong Kim, Laboratory of Molecular Signaling, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MD, USA" About Bill Huang Physicians and Surgeons, New York, USA; Division of Molecular Therapeutics, New York State Psychiatric Institute Boucard Antony A1. 1 Department of Cell Biology, Centro de Investigación y de Estudios Avanzados del Instituto

Hildebrand2, Norbert Sträter1 1 Institute of Bioanalytical Chemistry, Leipzig University, Deutscher Platz 5, 04103 Leipzig, Germany 2 Institute of Medical Physics and Biophysics, Leipzig University, Härtelstr . 16-18, D-04107 Leipzig 3 Rudolf-Schönheimer-Institute of Biochemistry, Division of General Biochemistry , Leipzig University, Johannisallee 30, D-04103 Leipzig 4 Rudolf-Schönheimer-Institute of Biochemistry Department of Pharmacology, Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN 37240, USA

independent research positions from 2001 at University of Sydney (opioids and sensory neurons), Vollum Institute Portland (visiting scientist with Ed McCleskey, sensory neuron properties); Pain Management Research Institute (more opioids, cannabinoids and T-type Ca channels) and Brain and Mind Research Institute (Sydney).

He completed postdoctoral training at the Weizmann Institute. In 1983, he joined the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health, in Bethesda, MD.